Skip to main content
Top
Published in: CEN Case Reports 2/2015

01-11-2015 | Case Report

Pediatric Sjogren syndrome with distal renal tubular acidosis and autoimmune hypothyroidism: an uncommon association

Authors: Amit Agarwal, Pradeep Kumar, Nomeeta Gupta

Published in: CEN Case Reports | Issue 2/2015

Login to get access

Abstract

A 14-year-old female came with the history of sudden onset weakness; during work up, she was found to have hyperchloremic metabolic acidosis with normal anion gap and normal renal function suggesting the possibility of renal tubular acidosis (RTA). On further evaluation of RTA, she had positive antinuclear antibody, anti-Ro, and anti-La antibodies. On nuclear scan of salivary glands, her left parotid gland was nonfunctional. Her parotid biopsy revealed dilated interlobular ducts engulfed by lymphoid cells. She also had autoimmune hypothyroidism as suggested by raised TSH and positive anti-TPO antibodies. At admission, her serum potassium levels were low and she was treated with intravenous potassium chloride. After she recovered from acute hypokalemic paralysis, she was started on oral potassium citrate along with phosphate supplements, hydroxychloroquine, oral prednisolone and thyroxine supplements. Over the next 6 months, she has significant reduction in the dosage of potassium, bicarbonate and phosphate and gained 3 kg of weight and 3.5 cm of height. As primary Sjogren syndrome itself is rare in pediatric population and its association with renal tubular acidosis is even rarer, we suggest considering Sjogren syndrome as a differential diagnosis during the RTA work-up is worth trying.
Literature
1.
go back to reference Vissink A, Bootsma H, Spijkervet F, et al. Current and future challenges in primary Sjogren’s syndrome. Curr Pharm Biotechnol. 2012;13:2026–45.CrossRefPubMed Vissink A, Bootsma H, Spijkervet F, et al. Current and future challenges in primary Sjogren’s syndrome. Curr Pharm Biotechnol. 2012;13:2026–45.CrossRefPubMed
2.
go back to reference Birlik M, Akar S, Gurler O, et al. Prevalence of primary Sjogren’s syndrome in Turkey: a population based epidemiological study. Int J Clin Pract. 2009;63(6):954–61.CrossRefPubMed Birlik M, Akar S, Gurler O, et al. Prevalence of primary Sjogren’s syndrome in Turkey: a population based epidemiological study. Int J Clin Pract. 2009;63(6):954–61.CrossRefPubMed
3.
go back to reference Trontzas PI, Andrianakos AA. Sjogren’s syndrome: a population based study of prevalence in Greece. The ESORDIG study. Ann Rheum Dis. 2005;64(8):1240–1.PubMedCentralCrossRefPubMed Trontzas PI, Andrianakos AA. Sjogren’s syndrome: a population based study of prevalence in Greece. The ESORDIG study. Ann Rheum Dis. 2005;64(8):1240–1.PubMedCentralCrossRefPubMed
4.
go back to reference Bartunkova J, Sediva A, Vencovsky J, Tesar V. Primary Sjogren’s syndrome (pSS) in children and adolescents: proposal for diagnostic criteria. Rheumatology. 1999;17:381–6. Bartunkova J, Sediva A, Vencovsky J, Tesar V. Primary Sjogren’s syndrome (pSS) in children and adolescents: proposal for diagnostic criteria. Rheumatology. 1999;17:381–6.
5.
go back to reference Bossini N, Savoldi S, Franceschini F, et al. Clinical and morphological features of kidney involvement in primary Sjogren’s syndrome. Nephrol Dial Transplant. 2001;16:2328–36.CrossRefPubMed Bossini N, Savoldi S, Franceschini F, et al. Clinical and morphological features of kidney involvement in primary Sjogren’s syndrome. Nephrol Dial Transplant. 2001;16:2328–36.CrossRefPubMed
6.
go back to reference Bogdanovic R, Jovanovic GB, Putnik J, Stajic N, Paripovic A. Renal involvement in primary Sjogren syndrome of childhood: case report and literature review. Mod Rheumatol. 2013;23:182–9.CrossRefPubMed Bogdanovic R, Jovanovic GB, Putnik J, Stajic N, Paripovic A. Renal involvement in primary Sjogren syndrome of childhood: case report and literature review. Mod Rheumatol. 2013;23:182–9.CrossRefPubMed
7.
go back to reference Bagga Arvind, Sinha Aditi. Evaluation of renal tubular acidosis. Indian J Pediatr. 2007;74(7):679–86.CrossRefPubMed Bagga Arvind, Sinha Aditi. Evaluation of renal tubular acidosis. Indian J Pediatr. 2007;74(7):679–86.CrossRefPubMed
8.
go back to reference Kobayashi I, Furuta H, Tame A, Kawamura N, Kojima K, Endoh M, Okano M, Sakiyama Y. Complications of childhood Sjogren syndrome. Eur J Pediatr. 1996;155:890–4.CrossRefPubMed Kobayashi I, Furuta H, Tame A, Kawamura N, Kojima K, Endoh M, Okano M, Sakiyama Y. Complications of childhood Sjogren syndrome. Eur J Pediatr. 1996;155:890–4.CrossRefPubMed
9.
go back to reference Zeher M, Horvath IF, Szanto A, Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren’s syndrome. Thyroid. 2009;19:39–45.CrossRefPubMed Zeher M, Horvath IF, Szanto A, Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren’s syndrome. Thyroid. 2009;19:39–45.CrossRefPubMed
10.
go back to reference Caramaschi Paola, Biasi Domenico, Caimmi Cristian, Scambi Cinzia, Pieropan Sara, Barausse Giovanni, Adami Silvano. The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype. Rheumatol Int. 2013;33:1271–5.CrossRefPubMed Caramaschi Paola, Biasi Domenico, Caimmi Cristian, Scambi Cinzia, Pieropan Sara, Barausse Giovanni, Adami Silvano. The co-occurrence of Hashimoto thyroiditis in primary Sjogren’s syndrome defines a subset of patients with milder clinical phenotype. Rheumatol Int. 2013;33:1271–5.CrossRefPubMed
11.
go back to reference Pessler F, Emery H, Dai L, et al. The spectrum of renal tubular acidosis in pediatric Sjogren syndrome. Rheumatology. 2006;45:85–91.CrossRefPubMed Pessler F, Emery H, Dai L, et al. The spectrum of renal tubular acidosis in pediatric Sjogren syndrome. Rheumatology. 2006;45:85–91.CrossRefPubMed
12.
go back to reference Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452–60.CrossRefPubMed Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452–60.CrossRefPubMed
13.
go back to reference Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Jean-Marie B, Perdriger A, Puéchal X et. al. Treatment of primary Sjo¨gren syndrome with rituximab :a randomized trial. Ann Intern Med. 2014;160:233–242. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Jean-Marie B, Perdriger A, Puéchal X et. al. Treatment of primary Sjo¨gren syndrome with rituximab :a randomized trial. Ann Intern Med. 2014;160:233–242.
14.
go back to reference Maripuri S, Grande JP, Osborn TG, et al. Renal involvement in primary Sjogren syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4:1423–31.PubMedCentralCrossRefPubMed Maripuri S, Grande JP, Osborn TG, et al. Renal involvement in primary Sjogren syndrome: a clinicopathologic study. Clin J Am Soc Nephrol. 2009;4:1423–31.PubMedCentralCrossRefPubMed
Metadata
Title
Pediatric Sjogren syndrome with distal renal tubular acidosis and autoimmune hypothyroidism: an uncommon association
Authors
Amit Agarwal
Pradeep Kumar
Nomeeta Gupta
Publication date
01-11-2015
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 2/2015
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-015-0169-y

Other articles of this Issue 2/2015

CEN Case Reports 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine